Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2003
11/13/2003CA2484303A1 Salt solution for colon cleansing
11/13/2003CA2484258A1 Soya cell strains with high isoflavone content
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2484173A1 4-azasteroid derivatives as androgen receptor modulators
11/13/2003CA2484162A1 Imidazo-triazine derivatives as ligands for gaba receptors
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2483846A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2483566A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
11/13/2003CA2483532A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
11/12/2003EP1361264A1 PRODUCTS CONTAINING $G(b)-GLUCAN
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto
11/12/2003EP1360299A2 The genome of a bifidobacterium
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360203A1 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
11/12/2003EP1360202A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
11/12/2003EP1360186A2 Carboline derivatives
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists
11/12/2003EP1360178A2 Novel heterocyclic analogs of diphenylethylene compounds
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359923A1 Use of selenite or preparations containing selenite for treating wounds
11/12/2003EP1359922A1 Novel receptors for $i(helicobacter pylori) and use thereof
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359912A2 Novel methods using pyridine derivatives
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1359816A1 Combination of probiotics
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1242402B1 Novel compounds
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1045687B1 Preparation for dental treatment
11/12/2003EP0775203B1 Method of gene therapy using dna vectors without selection marker gene
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/12/2003CN1455676A Chinese-herb composition and method for preparing same
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455667A Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
11/12/2003CN1455666A Externally-applicated chewing gum including chip-like center
11/12/2003CN1455662A Dental care compositions
11/12/2003CN1455661A New cosmetic, personal care, cleaning agent and nutritional supplement compositions containg bioactive glass and methods of making and using same
11/12/2003CN1454984A Health-care liquor
11/12/2003CN1454668A Anti-hepatitis-B-virus therapeutic vaccine and its adjuvant
11/12/2003CN1454664A Liver-recovering capsule
11/12/2003CN1454663A Compound artemisia rupestris capsule
11/12/2003CN1454661A Medicine for curing hepatitis B and preparing method thereof
11/12/2003CN1454651A Medicine for curing cardio-cerebrovascular disease
11/12/2003CN1454642A Tonifying capsule preparing process
11/12/2003CN1454641A Chinese medicine preparation for curing choleithiasis and cholecystitis and production method thereof
11/12/2003CN1454640A Gallbladder-clearing capsule
11/12/2003CN1454635A Eight-ingredient stomach-regulating oral liquid and preparing process thereof
11/12/2003CN1454628A Chinese medicine decoction for curing fatty liver
11/12/2003CN1454622A Chinese medicine for curing toothache
11/12/2003CN1454621A Chinese medicine for benefiting gallbladder and stomach
11/12/2003CN1454612A Cigarette for health-care and cure
11/12/2003CN1454603A Chinese medicine composition for curing hepatitis B and hepatitis B concurrent mental idness
11/12/2003CN1454595A Pharmaceutical composition comprising pyrroloquinoline quinone for curing and preventing fatty liver
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127497C Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
11/12/2003CN1127490C Cyclohexane derivatives difunctionalised in1,4 as ligands of 5-HT1A receptors
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/12/2003CN1127352C CCK antibodies used to improve feed efficiency
11/12/2003CN1127341C Medicine for treating dysentery
11/12/2003CN1127340C Composition containing nicotine compound, use thereof and its formation method
11/12/2003CN1127333C Local pharmaceutical composition comprising cholinergic agent or calcium channel blocker
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645988 Pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors with fast acting buffer; gastric acid stability for enteral administration
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645976 Indolizine SPLA2inhibitors
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003US6645955 3,6-dihydroxy-24-amidyl steroid derivatives
11/11/2003US6645940 Oligosaccharide derivatives and process for producing the same
11/11/2003US6645534 Process for the solvent extraction of active compounds from chicory
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003CA2348237C Methods of reducing the astringency of stannous in dentifrice compositions
11/11/2003CA2340070C Non-virulent porphyromonas gingivalis mutant
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/11/2003CA2144967C Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/11/2003CA2091440C 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as alpha adrenergic agents
11/06/2003WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003WO2003091429A1 Antimicrobial polypeptide and utizliation thereof
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
1 ... 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 ... 1258